SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of AMCOL International Corporation - ACO

NEW YORK, Feb. 12, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AMCOL International Corporation ("AMCOL" or the "Company") (NYSE: ACO) (ISIN: US02341W1036) (CUSIP: 02341W103) concerning the proposed acquisition of AMCOL by Imerys S.A.

The investigation concerns whether the AMCOL directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value.  Under the terms of the agreement, shares of AMCOL will be converted into the right to receive $41.00 in cash for each share of AMCOL common stock.  However, the Price to Revenue and Total Assets multiples are below the averages of comparable transactions.  Additionally, at least one analyst set a target price of $43.00 per share for AMCOL common stock.

AMCOL shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at [email protected] or 212-661-1100 or 888-476-6529, ext. 237.

Pomerantz LLP, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz LLP pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz LLP continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.

 

CONTACT:
Robert Willoughby
Pomerantz LLP
212-661-1100 ext. 237
[email protected]

SOURCE Pomerantz LLP

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.